Life sciences · Randomized Controlled Trial
New England Journal of Medicine · July 24, 2026
Strong and direct enough that it may change what you do.
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Multicenter, open-label, noninferiority RCT. Hospitalized adults with Gram-negative bacteremia. Intervention: 7 days of active antibiotics. Compared with: 14 days of active antibiotics. n = 604. 12 centers, 3 countries.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Supports shorter-duration stewardship targets and could reduce selection pressure driving resistance in your facilities.
As stated by the source record.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.